Live feed08:30:00·83dPRReleasevia QuantisnowTarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme DiseaseByQuantisnow·Wall Street's wire, on your screen.TARS· Tarsus Pharmaceuticals Inc.Health Care
